Skip to content
Trial Eligibility
Menu

Preventing Cognitive Decline by Reducing BP Target Trial

NCT05106036

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The PCOT study is a multi-site randomized trial of patients 70 years or older with high BP. The main goal of the study Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) is to conduct a large pragmatic clinical trial (PCT) to test the hypothesis that patients who receive care with a combination of clinical decision support (CDS) and team-based care delivered in primary care practices will have better blood pressure control and a lower incidence of mild cognitive impairment and dementia than patients receiving usual medical care.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Cognitive Decline
  • Blood Pressure
  • Hypertension

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
70 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Texas Southwestern Medical Center
Last updated on ClinicalTrials.gov
December 3, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • UT Southwestern Medical Center · Dallas, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.